The primary MS risk loci are the presence of HLA-DRB1*15:01 and the absence of HLA-A*02:01, which are amongst the 238 MS risk variants identified through genome-wide association studies (GWAS) [2,3]. This evidence concerns the gene HLA-DRB1 and myeloid sarcoma.